Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page
- Check5 days agoChange DetectedRemoved sponsor-related branding and multiple study-support resources from the Study Details page, including the Investigator Inquiry form and various helpful links and documents; this alters how users can contact investigators and access trial materials.SummaryDifference0.3%

- Check12 days agoChange DetectedAdded user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice ('No longer looking for participants'); updated the Intervention/Treatment label from 'Intervention / Treatment' to 'Intervention/Treatment' and bumped the site revision to v3.6.0 from v3.5.5.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a new build/version of the page without altering displayed study details.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision tag updated to v3.5.4, replacing the prior v3.5.3 tag to indicate a newer release of the page template or documentation.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a new website release of the study details page without altering the study information shown.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.